Copyright
©The Author(s) 2015.
World J Surg Proced. Jul 28, 2015; 5(2): 187-197
Published online Jul 28, 2015. doi: 10.5412/wjsp.v5.i2.187
Published online Jul 28, 2015. doi: 10.5412/wjsp.v5.i2.187
Figure 10 Neoadjuvant intraperitoneal/systemic chemotherapy.
Oral S-1 (Taiho Pharmaceutical Co., Ltd., Tokyo, Japan) is administered for 14 d at a dose of 60 mg/m2, following 7 d rest. Docetaxel (30 mg/m2) and cisplatin (CDDP) (30 mg/m2) are administered by intraperitoneal infusion on day 1 and days 8. Therapy is repeated three times, and laparptomy is done 3 to 4 wk after the last cycle.
- Citation: Yonemura Y, Canbay E, Endou Y, Ishibashi H, Mizumoto A, Li Y, Liu Y, Takeshita K, Ichinose M, Takao N, Saitou T, Noguchi K, Hirano M, Glehen O, Brűcher B, Sugarbaker PH. Comprehensive treatment for the peritoneal metastasis from gastric cancer. World J Surg Proced 2015; 5(2): 187-197
- URL: https://www.wjgnet.com/2219-2832/full/v5/i2/187.htm
- DOI: https://dx.doi.org/10.5412/wjsp.v5.i2.187